QCG
Quadrant Capital Group Portfolio holdings
AUM
$2.78B
This Quarter Return
-3.74%
1 Year Return
+19.13%
3 Year Return
+73.37%
5 Year Return
+122.71%
10 Year Return
+247.64%
AUM
$826M
AUM Growth
+$826M
(-1.5%)
Cap. Flow
+$32.5M
Cap. Flow
% of AUM
3.93%
Top 10 Holdings %
Top 10 Hldgs %
31.84%
Holding
2,811
New
181
Increased
1,190
Reduced
707
Closed
183
Top Buys
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
$9.7M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
$3.93M |
| 3 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
$2.7M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$1.56M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
$1.43M |
Top Sells
| 1 |
iShares Core 1-5 Year USD Bond ETF
ISTB
|
$7.89M |
| 2 |
JPMorgan Ultra-Short Income ETF
JPST
|
$2.34M |
| 3 |
Vanguard Real Estate ETF
VNQ
|
$1.68M |
| 4 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
$781K |
| 5 |
Meta Platforms (Facebook)
META
|
$452K |
Sector Composition
| 1 | Technology | 13.18% |
| 2 | Healthcare | 7.19% |
| 3 | Consumer Staples | 7.15% |
| 4 | Financials | 6.93% |
| 5 | Consumer Discretionary | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2801
ImmunityBio
IBRX
$2.21B
| – | – | -145 | Closed | -$1K |
|
2802
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.05B
| – | – | -16 | Closed | -$2K |
|
2803
iShares S&P Mid-Cap 400 Growth ETF
IJK
$9.07B
| – | – | -24 | Closed | -$2K |
|
2804
Informatica
INFA
$7.6B
| $0 | ﹤0.01% | +7 | New | – |
|
2805
Inogen
INGN
$216M
| – | – | -11 | Closed | – |
|
2806
Insmed
INSM
$28.8B
| – | – | -6 | Closed | – |
|
2807
iRadimed
IRMD
$921M
| – | – | -57 | Closed | -$3K |
|
2808
Ironwood Pharmaceuticals
IRWD
$214M
| $0 | ﹤0.01% | 38 +16 | +73% | – |
|
2809
iShares US Technology ETF
IYW
$22.9B
| – | – | -755 | Closed | -$87K |
|
2810
James River Group
JRVR
$258M
| $0 | ﹤0.01% | +21 | New | – |
|
|
KC
2811
Kingsoft Cloud Holdings
KC
$4.04B
| – | – | -803 | Closed | -$13K |
|